Patients’ adherence to anti-tuberculosis medicines and associated factors for non-adherence at a tertiary teaching hospital, South West Ethiopia

Misganu Diriba Daksa; Tsegaye Melaku Kebede; Desta Assefa H/MarIam

doi:10.5578/gmj.32149

Authors

Misganu Diriba Daksa School of Pharmacy, Collage of Health Sciences, Jimma University, Jimma, Ethiopia
Tsegaye Melaku Kebede School of Pharmacy, Collage of Health Sciences, Jimma University, Jimma, Ethiopia
Desta Assefa H/MarIam School of Pharmacy, Collage of Health Sciences, Jimma University, Jimma, Ethiopia

DOI:

https://doi.org/10.5578/gmj.32149

Keywords:

Adherence, tuberculosis, treatment failure, directly observed therapy, Jimma University Specialized Hospital

Abstract

Introduction: Tuberculosis is the global problem, which may infect one third of the world population annually. A major contributor for the re-emergence of TB is lack of adherence to anti-TB drugs. Non-adherence to anti-TB treatment is the persistent problem throughout the world, including the developing and developed countries. The main objective of this study was to determine the rate of non-adherence to anti-TB treatment and associated factors for non-adherence among TB patients in Jimma University Specialized Hospital.

Materials and Methods: Prospective cross sectional study was conducted in TB clinic of Jimma University Specialized Hospital using pretested structured questionnaire from February 10, 2013, to February 20, 2013

Results: From a total of 67 patients interviewed during the study period, majority of them (83.58%) were between 18-40 years. About 88% of patients were adherent to their medication and the rest missed doses at least once during the course of their treatment. The main reasons for non-adherence were lack of family support (37.50%) and far distance from hospital (25%). Less education and HIV positive have association with non-adherence (p< 0.001).

Conclusion: Generally the adherence to anti-TB treatment among TB patients in Jimma University Specialized Hospital was good, even though some patients were missing their treatments.

Metrics

Metrics Loading ...

References

WHO. Global report on tuberculosis, Geneva, Switzerland. 2012;8-25.

MOH. National tuberculosis, Leprosy TB/HIV Control programme Manual, 4th ed. Ethiopia: Addis Ababa, 2008;2-4.

Health module, communicable disease, Tuberculosis burden in Ethiopia, 2010.

WHO regional office for Europe, The Global Plan to Stop TB, Copenhagen, Denmark, EUR/TB/FS013 September 2007:1-2.

Boogaard JV. Non-adherence to tuberculosis treatment: An integral approach to measure and prevent it. Radboud University, Nijmegen, 2011;275.

van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study. Bull World Health Organ 2011;89(9):632-9.

Zeleke. Ethiopian national TB prevalence surveys preliminary result; Lille, France 2010-2011.

Balchi S, Anbe W, Sathiakumar N. Determinant of poor adherence to anti-tuberculosis treatment in Mumbai, India. Int J Prev Med 2010;1(4):223-32.

Castlenuovo B. A review of compliance to Anti- tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa. Afr Health Sci 2010;10(4):320-4.

Ansari Md, Khayyam KU, Sharma M, et al. The role of socioeconomic factors responsible for non-compliance of DOTS among tuberculosis patients, New Delhi, India. Journal of Medicine and Health Sciences 2011;18:2-9.

Chani K. Factors affecting compliance to tuberculosis treatment in Andarakavango region, Namibia. Int J Prev Med 2010;1(4):223-32.

Culqui DR, Munayco E CV, Grijalva CG, Cayla JA, Horna-Campos O, Alva Ch K, et al. Factors associated with the non-completion of conventional anti-TB treatment, Peru. Arch Bronconeumol 2010;48(5):150-5.

Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 2007;85(9):703-11.

Khan A, Usmani A, Sultana A. Risk factors in development of MDRTB in the hospitalized patients, Pakistan. Journal of Army Crops 2005;4:30-9648.

Starr B, Sacks R. Improving outcomes for patients with chronic disease: medication adherence project, New York City, 2010;8.

Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis 2005 Jun;58(3):152-8.

Yone EWP, Kengne AP, Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaoundé, Cameroon. BMJ Open 2011;1:e000289 doi: 10.1136/bmjopen-2011-000289.

Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN. Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors. Afr Health Sci 2009;(9 Suppl 1):S8-S15.